NURS 6521 Basic Pharmacotherapeutic Concepts/Ethical and Legal Aspects of Prescribing

NURS 6521 Basic Pharmacotherapeutic Concepts/Ethical and Legal Aspects of Prescribing

NURS 6521 Basic Pharmacotherapeutic Concepts/Ethical and Legal Aspects of Prescribing

The promotion of safety and quality in the prescription of medications is imperative in nursing practice. Advanced registered nurses make treatment decisions based on best practices available and utilize interprofessional collaboration to optimize treatment outcomes. Therefore, this paper explores the ethics of prescribing a new drug, which has not been approved to a 7-year-old child for asthma.

Having Trouble Meeting Your Deadline?

Get your assignment on NURS 6521 Basic Pharmacotherapeutic Concepts/Ethical and Legal Aspects of Prescribing  completed on time. avoid delay and – ORDER NOW

Ethical and Legal Implications

          The prescription of unapproved drug to the 7-year-old child is associated with significant ethical and legal implications to the nurses’ role in practice. First, the new drug has not been tested or approved for its efficiency and effectiveness in asthma treatment. The drug has also not been used in children under the age of 12 years. As a result, it raises the concerns related to the safety of the drug(Woo et al., 2019). The drug predisposes the 7-year-old to harm because of the lack of information about its safety in children below 12 years.

          The prescription of the new drug to the 7-year-old violates the nurses’ code of ethics and standards of practice. Advanced registered nurses have the professional and legal responsibility of promoting safety, quality, and efficiency in their practice. They make decisions based on best available evidence, practice guidelines, and protection of the patient’s rights in the treatment process. The professional standards of practice require them to make decisions that minimize harm while optimizing treatment benefits(Grace & Uveges, 2022). The new drug has never been tested or studied to determine its safety and efficacy profile. Therefore, prescribing the drug will violate the stated codes of practice and ethics in nursing.

nursing masters

Struggling to Meet Your Deadline?

Get your assignment on NURS 6521 Basic Pharmacotherapeutic Concepts/Ethical and Legal Aspects of Prescribing done on time by medical experts. Don’t wait – ORDER NOW!

Strategies to Address Disclosure and Non-Disclosure

          Disclosure and non-disclosure influence the actions that nurses implement in their practice. disclosure entails the provider informing the patient and their significant others about the events that have happened to them in the care process. Advanced practice nurses have the professional obligation to inform their patients about any health interventions implemented to promote their health and recovery. The code of ethics by the American Nurses Association requires that nurses should promote and advocate the patients’ rights, safety, health, and wellbeing(Passini et al., 2023). Non-disclosure entails not informing the patients about any events that have happened to them in the care process.

          The state of California requires that healthcare providers to disclose any information that influences health and outcomes to the patients. The disclosure includes providing information about any error that has been made in the delivery of the care. The patient then makes the decision to either share the information with other people or not. The disclosure will also extend to the hospital’s management for the implementation of interventions that will minimize error occurrence in the future. Disclosure of information would promote patient’s autonomy, beneficence, and non-maleficence in the treatment process(Fairchild, 2021). Non-disclosure will translate into nurse’s lack of professional responsibility and negligence, which violates provision 3 of the American Code of Ethics for nurses.

Strategies to Guide Decision Making

          One of the strategies that I will adopt to guide my decision-making is interprofessional collaboration. I will involve the other healthcare providers in assessing if we should prescribe the new drug to the 7-year-old. Interprofessional collaboration will ensure the collective examination of the potential alternatives that we may consider to optimize outcomes in the treatment process. Collaboration will also enable the team to examine any evidence that supports the use of the new drug in the treatment and potential risks if any(Donnelly et al., 2021). Therefore, interprofessional collaboration will ensure the adoption of an ethical and most relevant solution in the scenario.

          The second strategy that I will use to guide my decision making is relying on the set organizational policies and guidelines. Health organizations have policies that guide nurses in making decisions. The guidelines limit the nurses’ involvement in activities that predispose patients to unintended harm. Relying on them will ensure that I make an informed decision about the issue(Grace & Uveges, 2022). I will disclose the error. As noted above, disclosure is crucial to promote the adoption of interventions that will minimize any harm. Disclosure will also ensure accountability and professional responsibility as an advanced practice nurse.

Process of Writing Prescriptions and Strategies to Minimize Medication Errors

          Writing prescriptions should follow developed guidelines to minimize medication errors. One of the processes in writing prescriptions is writing clearly and accurately the patient’s data such as name, age, gender, and diagnosis. Information about the medication name should also be written clearly and accurately to avoid confusion. The prescriber should avoid abbreviations and illegible writing. The dosage information should be concise with clear and specific directions. The therapeutic duration of the drug should also be specific alongside the drug’s therapeutic intervention. Any supplemental instructions such as medication refill or warnings should also be included. The strategies that can be adopted to minimize medication errors include provider training and education about best practices, use of health technologies, double checking and encouraging open reporting of medication errors(Royce et al., 2019; Sutton et al., 2020).

Conclusion

          The promotion of safety and quality in prescribing medications is important. I will disclose the medication error. The issue has significant and ethical implications to nursing practice. Advanced registered nurses should adopt best practices that minimize errors in their practice.

References

Donnelly, S., Ó Coimín, D., O’Donnell, D., Ní Shé, É., Davies, C., Christophers, L., Mc Donald, S., & Kroll, T. (2021). Assisted decision-making and interprofessional collaboration in the care of older people: A qualitative study exploring perceptions of barriers and facilitators in the acute hospital setting. Journal of Interprofessional Care, 35(6), 852–862. https://doi.org/10.1080/13561820.2020.1863342

Fairchild, A. (2021). The ethical conflict of truth, hope, and the experience of suffering: A discussion of non-disclosure of terminal illness and clinical placebos. Clinical Ethics, 16(2), 130–136. https://doi.org/10.1177/1477750920959556

Grace, P. J., & Uveges, M. K. (2022). Nursing Ethics and Professional Responsibility in Advanced Practice. Jones & Bartlett Learning.

Passini, L., Bouedec, S. L., Dassieu, G., Reynaud, A., Jung, C., Keller, M.-L., Lefebvre, A., Katty, T., Baleyte, J.-M., Layese, R., Audureau, E., &Caeymaex, L. (2023). Error disclosure in neonatal intensive care: A multicentre, prospective, observational study. BMJ Quality & Safety. https://doi.org/10.1136/bmjqs-2022-015247

Royce, C. S., Hayes, M. M., &Schwartzstein, R. M. (2019). Teaching Critical Thinking: A Case for Instruction in Cognitive Biases to Reduce Diagnostic Errors and Improve Patient Safety. Academic Medicine, 94(2), 187. https://doi.org/10.1097/ACM.0000000000002518

Sutton, R. T., Pincock, D., Baumgart, D. C., Sadowski, D. C., Fedorak, R. N., & Kroeker, K. I. (2020). An overview of clinical decision support systems: Benefits, risks, and strategies for success. Npj Digital Medicine, 3(1), Article 1. https://doi.org/10.1038/s41746-020-0221-y

Woo, B. F. Y., Zhou, W., Lim, T. W., & Tam, W. W. S. (2019). Practice patterns and role perception of advanced practice nurses: A nationwide cross-sectional study. Journal of Nursing Management, 27(5), 992–1004. https://doi.org/10.1111/jonm.12759

How do beta-blockers work? What exactly do antibiotics do to the bacteria they target? What effects does an anti-depressant have on blood flow?

Questions like these are related to the underlying pharmacokinetic and pharmacodynamic processes of pharmacotherapeutics. As an advanced practice nurse, understanding these fundamental pharmacotherapeutic concepts is important to ensure that the prescription drugs you recommend for your patients will be safe and effective to treat and/or manage their symptoms. Additionally, as the advanced practice nurse, it is your responsibility to ensure that when prescribing prescription drugs, you adhere to the ethical and legal principles set forth for prescribing drugs as an added layer of protection and safety for the patients you will treat.

This week, you will analyze factors that may influence pharmacokinetic and pharmacodynamics processes of a patient and assess the details of a personalized plan of care that you develop based on influencing factors and patient history. You will also evaluate and analyze ethical and legal implications and practices related to prescribing drugs, including disclosure and nondisclosure, and analyze the process of writing prescriptions to avoid medication errors.

Learning Objectives

Students will:

  • Analyze factors that influence pharmacokinetic and pharmacodynamic processes in patients
  • Assess patient factors and history to develop personalized plans of care
  • Evaluate ethical and legal implications related to prescribing drugs
  • Analyze ethical and legal practices of prescribing drugs
  • Analyze strategies to address disclosure and nondisclosure
  • Justify advanced practice nurse strategies to guide prescription drug decision-making
  • Analyze the process of writing prescriptions to avoid medication errors

Learning Resources

Required Readings (click to expand/reduce)

Rosenthal, L. D., & Burchum, J. R. (2021). Lehne’s pharmacotherapeutics for advanced practice nurses and physician assistants (2nd ed.) St. Louis, MO: Elsevier.

  • Chapter 1, “Prescriptive Authority” (pp. 1–3)
  • Chapter 2, “Rational Drug Selection and Prescription Writing” (pp. 4–7)
  • Chapter 3, “Promoting Positive Outcomes of Drug Therapy” (pp. 8–12)
  • Chapter 4, “Pharmacokinetics, Pharmacodynamics, and Drug Interactions” (pp. 13–33)
  • Chapter 5, “Adverse Drug Reactions and Medication Errors” (pp. 34–42)
  • Chapter 6, “Individual Variation in Drug Response” (pp. 43–45)

American Geriatrics Society 2019 Beers Criteria Update Expert Panel. (2019). American Geriatrics Society 2019 updated AGS Beers criteria for potentially inappropriate medication use in older adults. Journal of the American Geriatrics Society, 67(4), 674–694. doi:10.1111/jgs.15767

American Geriatrics Society 2019 updated AGS Beers criteria for potentially inappropriate medication use in older adults by American Geriatrics Society, in Journal of the American Geriatrics Society, Vol. 67/Issue 4. Copyright 2019 by Blackwell Publishing. Reprinted by permission of Blackwell Publishing via the Copyright Clearance Center.

 

This article is an update to the Beers Criteria, which includes lists of potentially inappropriate medications to be avoided in older adults as well as newly added criteria that lists select drugs that should be avoided or have their dose adjusted based on the individual’s kidney function and select drug-drug interactions documented to be associated with harms in older adults.

Drug Enforcement Administration. (n.d.-a). Code of federal regulations. Retrieved February 1, 2019, from https://www.deadiversion.usdoj.gov/21cfr/cfr/1300/1300_01.htm

 

This website outlines the code of federal regulations for prescription drugs.

Drug Enforcement Administration. (n.d.-b). Mid-level practitioners authorization by state. Retrieved May 13, 2019 from http://www.deadiversion.usdoj.gov/drugreg/practioners/index.html

 

This website outlines the schedules for controlled substances, including prescriptive authority for each schedule.

Drug Enforcement Administration. (2006). Practitioner’s manual. Retrieved from http://www.legalsideofpain.com/uploads/pract_manual090506.pdf
This manual is a resource for practitioners who prescribe, dispense, and administer controlled substances. It provides information on general requirements, security issues, recordkeeping, prescription requirements, and addiction treatment programs.

Drug Enforcement Administration. (n.d.-c). Registration. Retrieved February 1, 2019, from https://www.deadiversion.usdoj.gov/drugreg/index.html

Click here to ORDER an A++ paper from our Verified MASTERS and DOCTORATE WRITERS: NURS 6521 Basic Pharmacotherapeutic Concepts/Ethical and Legal Aspects of Prescribing

This website details key aspects of drug registration.

Fowler, M. D. M., & American Nurses Association. (2015). Guide to the code of ethics for nurses with interpretive statements: Development, interpretation, and application (2nd ed.). American Nurses Association.

This resource introduces the code of ethics for nurses and highlights critical aspects for ethical guideline development, interpretation, and application in practice.

Institute for Safe Medication Practices. (2017). List of error-prone abbreviations, symbols, and dose designations. Retrieved from https://www.ismp.org/recommendations/error-prone-abbreviations-list

 

This website provides a list of prescription-writing abbreviations that might lead to misinterpretation, as well as suggestions for preventing resulting errors.

Ladd, E., & Hoyt, A. (2016). Shedding light on nurse practitioner prescribing. The Journal for Nurse Practitioners, 12(3), 166–173. doi:10.1016/j.nurpra.2015.09.17

This article provides NPs with information regarding state-based laws for NP prescribing.

Sabatino, J. A., Pruchnicki, M. C., Sevin, A. M., Barker, E., Green, C. G., & Porter, K. (2017). Improving prescribing practices: A pharmacist‐led educational intervention for nurse practitioner students. Journal of the American Association ofNursePractitioners, 29(5), 248–254. doi:10.1002/2327-6924.12446

The authors of this article assess the impact of a pharmacist‐led educational intervention on family nurse practitioner (FNP) students’ prescribing skills, perception of preparedness to prescribe, and perception of pharmacist as collaborator.

Required Media (click to expand/reduce)

Introduction to Advanced Pharmacology

Meet Dr. Terry Buttaro, associate professor of practice at Simmons College of Nursing and Health Sciences as she discusses the importance of pharmacology for the advanced practice nurse. (8m)

Nature Video. (2016). The evolution of oral anticoagulants [Video]. https://www.youtube.com/watch?v=Gp-ucDRiaUA
Note:
This media program is approximately 5 minutes.

Speed Pharmacology. (2015). Pharmacology Pharmocokinetics (Made Easy) [Video]. https://www.youtube.com/watch?v=NKV5iaUVBUI&t=16s
Note: This media program is approximately 14 minutes.

Speed Pharmacology. (2017).  Pharmacology Diuretics (Made Easy) [Video]. https://www.youtube.com/watch?v=9OBvNpnS0h4&t=664s
Note:
This media program is approximately 18 minutes.

Speed Pharmacology. (2017). Pharmacology Antiarrhythmic Drugs (Made easy) [Video]. https://www.youtube.com/watch?v=9xSqezCMHnw&t=1205s
Note:
This media program is approximately 23 minutes.

Speed Pharmacology. (2015). Pharmacology Pharmocokinetics (Made Easy) [Video]. https://www.youtube.com/watch?v=NKV5iaUVBUI&t=16s
Note: This media program is approximately 14 minutes.

Speed Pharmacology. (2016). Pharmacology – Adrenergic receptors & agonists (MADE EASY) [Video]. https://www.youtube.com/watch?v=KtmV-yMDYPI&t=372s
Note: This media program is approximately 18 minutes.

Speed Pharmacology. (2017). Drugs for Hyperlipidemia (Made Easy) [Video]. https://www.youtube.com/watch?v=Of1Aewx-zRM&t=24s
Note:
This media program is approximately 14 minutes.

Discussion: Pharmacokinetics and Pharmacodynamics

As an advanced practice nurse assisting physicians in the diagnosis and treatment of disorders, it is important to not only understand the impact of disorders on the body, but also the impact of drug treatments on the body. The relationships between drugs and the body can be described by pharmacokinetics and pharmacodynamics.

Pharmacokinetics describes what the body does to the drug through absorption, distribution, metabolism, and excretion, whereas pharmacodynamics describes what the drug does to the body.

Photo Credit: Getty Images/Ingram Publishing

When selecting drugs and determining dosages for patients, it is essential to consider individual patient factors that might impact the patient’s pharmacokinetic and pharmacodynamic processes. These patient factors include genetics, gender, ethnicity, age, behavior (i.e., diet, nutrition, smoking, alcohol, illicit drug abuse), and/or pathophysiological changes due to disease.

For this Discussion, you reflect on a case from your past clinical experiences and consider how a patient’s pharmacokinetic and pharmacodynamic processes may alter his or her response to a drug.

To Prepare

  • Review the Resources for this module and consider the principles of pharmacokinetics and pharmacodynamics.
  • Reflect on your experiences, observations, and/or clinical practices from the last 5 years and think about how pharmacokinetic and pharmacodynamic factors altered his or her anticipated response to a drug.
  • Consider factors that might have influenced the patient’s pharmacokinetic and pharmacodynamic processes, such as genetics (including pharmacogenetics), gender, ethnicity, age, behavior, and/or possible pathophysiological changes due to disease.
  • Think about a personalized plan of care based on these influencing factors and patient history in your case study.

By Day 3 of Week 1

Post a description of the patient case from your experiences, observations, and/or clinical practice from the last 5 years. Then, describe factors that might have influenced pharmacokinetic and pharmacodynamic processes of the patient you identified. Finally, explain details of the personalized plan of care that you would develop based on influencing factors and patient history in your case. Be specific and provide examples.

By Day 6 of Week 1

Read a selection of your colleagues’ responses and respond to at least two of your colleagues on two different days by suggesting additional patient factors that might have interfered with the pharmacokinetic and pharmacodynamic processes of the patients they described. In addition, suggest how the personalized plan of care might change if the age of the patient were different and/or if the patient had a comorbid condition, such as renal failure, heart failure, or liver failure.

Note: For this Discussion, you are required to complete your initial post before you will be able to view and respond to your colleagues’ postings. Begin by clicking on the “Post to Discussion Question” link, and then select “Create Thread” to complete your initial post. Remember, once you click on Submit, you cannot delete or edit your own posts, and you cannot post anonymously. Please check your post carefully before clicking on Submit!

Submission and Grading Information

Grading Criteria

To access your rubric:

Week 1 Discussion Rubric

Post by Day 3 of Week 1 and Respond by Day 6 of Week 1

To Participate in this Discussion:

Week 1 Discussion

Assignment: Ethical and Legal Implications of Prescribing Drugs

What type of drug should you prescribe based on your patient’s diagnosis? How much of the drug should the patient receive? How often should the drug be administered? When should the drug not be prescribed? Are there individual patient factors that could create complications when taking the drug? Should you be prescribing drugs to this patient? How might different state regulations affect the prescribing of this drug to this patient?

These are some of the questions you might consider when selecting a treatment plan for a patient.

Photo Credit: Getty Images/Caiaimage

As an advanced practice nurse prescribing drugs, you are held accountable for people’s lives every day. Patients and their families will often place trust in you because of your position. With this trust comes power and responsibility, as well as an ethical and legal obligation to “do no harm.” It is important that you are aware of current professional, legal, and ethical standards for advanced practice nurses with prescriptive authority. Additionally, it is important to ensure that the treatment plans and administration/prescribing of drugs is in accordance with the regulations of the state in which you practice. Understanding how these regulations may affect the prescribing of certain drugs in different states may have a significant impact on your patient’s treatment plan. In this Assignment, you explore ethical and legal implications of scenarios and consider how to appropriately respond.

To Prepare

  • Review the Resources for this module and consider the legal and ethical implications of prescribing prescription drugs, disclosure, and nondisclosure.
  • Review the scenario assigned by your Instructor for this Assignment.
  • Search specific laws and standards for prescribing prescription drugs and for addressing medication errors for your state or region, and reflect on these as you review the scenario assigned by your Instructor.
  • Consider the ethical and legal implications of the scenario for all stakeholders involved, such as the prescriber, pharmacist, patient, and patient’s family.
  • Think about two strategies that you, as an advanced practice nurse, would use to guide your ethically and legally responsible decision-making in this scenario, including whether you would disclose any medication errors.

By Day 7 of Week 1

Write a 2- to 3-page paper that addresses the following:

  • Explain the ethical and legal implications of the scenario you selected on all stakeholders involved, such as the prescriber, pharmacist, patient, and patient’s family.
  • Describe strategies to address disclosure and nondisclosure as id

Similar Posts